DrShahidaDin
@ShahidaDin1
Followers
2K
Following
13K
Statuses
3K
Gastroenterologist. IBD Researcher. Chair of the 🇬🇧 Society of Gastroenterology Inflammatory Bowel Disease (IBD) Committee
Edinburgh, Scotland
Joined February 2019
Several stakeholders have advocated for minimising placebo controlled RCTs. We analysed the harms [Adverse Events,[AEs]] associated with placebo in inflammatory bowel diseases (IBD) RCTs. @alex_ford12399 @Bealoquebea @Jonathansegal85 @JonnyBlackwell @DrCJBlack @GastroRes_Leeds
7
50
101
@Bealoquebea Congratulations! @Bealoquebea Your amazing. 🤩 What a huge blessing to have you sharing your passion for learning with us all without boundaries or borders. Excited at what you will bring next. 🥰
1
1
4
RT @Bealoquebea: Thanks @fgomollon @ShahidaDin1 @JonnyBlackwell @DCharabaty @charlie_lees @anjan_dhar6 @ibdseb @ShomronH @HenitYanaiMD @Jon…
0
1
0
RT @Bealoquebea: Two years ago, I had a crazy idea one I never thought would go this far I've always believed that we should never leave a…
0
28
0
RT @NDSPolicyGroup: An open letter signed by 60+ organisations raises serious concerns about the potential impacts of legalising assisted d…
0
147
0
RT @GordonMoranIBD: We are looking for Healthcare professionals and people with IBD to contribute to a survey study to better understand ho…
0
4
0
RT @Jonathansegal85: My academic work has occurred in my own time without protected academic time A wise person told me eventually this be…
0
8
0
@Bealoquebea the best slide ever! 🙏🏽to @ebtapper
Someone updated this timeline from I dont know who would have done such a thing Again, I am just a hepatologist. Don't be mad!
2
2
5
RT @ebtapper: Someone updated this timeline from I dont know who would have done such a thing Again, I am just a…
0
5
0
RT @NutrioSci: Patients with moderately to severely active IBD receiving placebo are more likely to experience significant worsening of IBD…
0
3
0
RT @Jonathansegal85: @NatRevGastroHep Placebo IBD studies may be associated with harms to IBD patients. Especially those re-randomised to p…
0
2
0
RT @JKurowskiMD: DOUBLE the risk for any serious worsening of disease activity in placebo arm vs drug arm in 29 IBD RCTs. Put the FDA on n…
0
6
0
RT @Y_ECCO_IBD: On the Need for Equipoise and Placebos: Well-Executed Studies Answering the Wrong Questions @AGA_Gastro With reply - http…
0
2
0
Thank you for highlighting the letter and Reply - it is important that the wider IBD community appreciate the challenges of inflammatory bowel disease clinical trials & regulatory approval
On the Need for Equipoise and Placebos: Well-Executed Studies Answering the Wrong Questions @AGA_Gastro With reply - Important discussion re: ongoing use of placebo-control - how can progress be made by regulators? @US_FDA
0
3
7
RT @vipuljairath: Top feedback from IBD patients who took part in drug trials was reduce burden of questionnaires, colonoscopy, placebo, al…
0
8
0
RT @vipuljairath: Excellent review: Bayesian approaches in drug development. IBD trials should routinely incorporate well established metho…
0
5
0
RT @Jonathansegal85: When enrolling a patient in a placebo controlled RCT in #IBD if you aren’t consenting for the possibility of worsening…
0
2
0
RT @Jonathansegal85: Imagine being sick failing multiple lines of treatment for #IBD then being enrolled to a RCT trial where you receive a…
0
3
0
RT @Y_ECCO_IBD: Outstanding talk by Prof Jairath @vipuljairath on innovations needed for clinical trials in IBD #UEGWeek2023 🌠Reduced pla…
0
22
0
@JonnyBlackwell @David_J_Adams @ProfWhelan Precisely! That is why our tools to chatacterise the Crohn’s disease gut cell atlas by location are so vital in unravelling disease heterogeneity @HelmsleyTrust @PathologyEdin @C15MNW @David_J_Adams @irenepapatheodo
0
1
4